Biotechnology
Jobs at Avidity
About Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
- Industry
- Biotechnology
- Open roles
- 46
Open positions
Explore roles at Avidity
Showing 46 of 46 roles
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.
Avidity
Avidity is a clinical-stage biopharmaceutical company focused on developing novel antibody-based therapeutics for cancer.